The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Overview of attention for article published in Psychopharmacology, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 19 news outlets
blogs: 4 blogs
twitter: 34 X users

facebook: 1 Facebook page
q&a: 1 Q&A thread

Citations

dimensions_citation: 171 Dimensions

Readers on

mendeley: 394 Mendeley

Summary News Blogs X Facebook Q&A Dimensions citations

So far, Altmetric has seen 1 public wall post.

Psych Unseen, 15 Sep 2018

in contrast to previous 2 studies, a 3rd published RCT on the effects of #cannabidiol CBD for #schizophrenia is negative. now…